News Focus
News Focus
Followers 20
Posts 802
Boards Moderated 0
Alias Born 09/14/2013

Re: NASDAQ2020 post# 423466

Monday, 03/24/2025 6:14:59 PM

Monday, March 24, 2025 6:14:59 PM

Post# of 445372
How do we determine/value a fair stock price for ELTP?
1. Methotrexate launched on 8/27/24 ~$63 Million market  https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Generic-Methotrexate-Sodium-8-27-2024

2. Codeine with acetaminophen launched on 10/7/24 ~$47 Million market https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Acetaminophen-and-Codeine-Phosphate-Tablets-10-7-2024

3. Hydrocodone with acetaminophen launched on 12/2/24 ~$300 Million market https://elite.irpass.com/irpass.asp?ResLibraryID=140659&BzID=2258&L=1&s=0&G=939&Nav=0

4. Generic Vyvanse launched on 12/26/24 ~$4.3 Billion martket https://elite.irpass.com/irpass.asp?ResLibraryID=141273&BzID=2258&L=1&s=0&G=939&Nav=0
5.Elite Pharmaceuticals, Inc. Announces First Shipment Of Product From New Facility And Packaging Line
https://elite.irpass.com/Elite-Pharmaceuticals--Inc--Announces-First-Shipment-of-Product-from-New-Facility-and-Packaging-Line-3-3-2025
6.Abuse Deterrent Technology 
Many catalysts are on deck to fuel ELTP to rocket up again.
1. Launch of generic Percocet in less than 7 days.~$500 million market
2. Launch of generic Dolophine (methadone) ~before or on 5/30/25 ~$30 million market
3. Pending acquisition and merger news
4. Pending generic Adderall IR launch in Israel
5.  Pending positive ruling for Elite with generic OxyContin
6. Record breaking quarterly revenue report on  6/30/25
7. April 1 - Elite terminates Prasco Agreement and begins marketing Adderall XR 100% by themselves
8. April 2- Tariffs begin - wild card for merger/acquisition premium 
https://thehill.com/policy/healthcare/5164970-eli-lilly-27-billion-new-domestic-plants/amp/
https://www.reuters.com/business/jj-plans-invest-more-than-55-billion-us-over-next-four-years-2025-03-21/
9. Pending Dopamine Agonist approval
10. Pending India R&D Agreement signed
11. Pending Positive BE studies (Concerta and Undisclosed)
https://fullratio.com/pe-ratio-by-industry
Share Price = EPS x P/E Ratio$0.2172 = $.01 x 21.72$0.4344 = $.02 x 21.72$0.6516 = $.03 x 21.72$0.8688 = $.04 x 21.72$1.0860 = $.05 x 21.72$1.3032 = $.06 x 21.72$1.5204 = $.07 x 21.72$1.7376 = $.08 x 21.72$1.9548 = $.09 x 21.72$2.1720 = $.10 x 21.72
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News